Effect of mirtazapine treatment on body composition and metabolism

The Journal of Clinical Psychiatry
Markus LaimerChristoph F Ebenbichler

Abstract

Weight gain is a common side effect of psychotropic medications. Mirtazapine, a widely used antidepressant, induces adverse metabolic effects such as an increase in body weight. The aim of this study was to investigate the influence of mirtazapine treatment on body weight, body fat mass, glucose metabolism, lipoprotein profile, and leptin and its soluble receptor in a prospective, controlled study design. Seven women who met the ICD-10 diagnostic criteria for a depressive episode (ICD-10: F31-F33) were assigned to monotherapy with mirtazapine and observed for a 6-week period. Seven mentally and physically healthy female volunteers matched for age and body weight served as a control group. Data were collected from November 2002 to December 2003. The mean +/- SD body weight increased from 63.6 +/- 13.1 kg to 66.6 +/- 11.9 kg during mirtazapine treatment (p = .027). Fat mass increased in study subjects from 20.9 +/- 9.6 kg to 22.1 +/- 9.3 kg (p = .018). Insulin, glucose, and the homeostasis model assessment (HOMA) index for insulin resistance and lipid parameters remained stable. Leptin concentrations increased from 23.0 +/- 17.1 ng/mL to 40.9 +/- 27.2 ng/mL (p = .018), whereas the soluble leptin receptor concentrations remained s...Continue Reading

Citations

Oct 17, 2012·Der Nervenarzt·M Deuschle, U Schweiger
Jun 4, 2010·Psychopharmacology·Margaret HaneyRichard W Foltin
Jul 28, 2011·Wiener medizinische Wochenschrift·Claudia RessChristoph F Ebenbichler
Apr 14, 2011·International Journal of Clinical Pharmacy·Star Khoza, Jamie C Barner
Nov 29, 2012·Current Opinion in Psychiatry·Michael Deuschle
Sep 21, 2013·Indian Journal of Psychological Medicine·Sandeep GroverParmanand Kulhara
Jan 16, 2008·European Journal of Clinical Pharmacology·Hieronymus J DerijksAntoine C G Egberts
Feb 12, 2014·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Olga Hilas, Carmela Avena-Woods
Jun 16, 2006·Expert Opinion on Drug Safety·Roger S McIntyreSidney H Kennedy
Jan 29, 2016·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Francisca M ScoralickOtávio T Nóbrega
Nov 13, 2015·Progress in Cardiovascular Diseases·Robyn M TeplyJames J DiNicolantonio
Mar 16, 2016·Neuroscience and Biobehavioral Reviews·Deepali GuptaMahesh Radhakrishnan
Jul 2, 2009·Australasian Journal on Ageing·UNKNOWN Australian and New Zealand Society for Geriatric Medicine
Sep 29, 2011·Pharmacotherapy·Stephanie V Phan, Tiffany-Jade M Kreys
Jul 14, 2010·Phytotherapy Research : PTR·Solmaz AsnaashariSatyajit D Sarker
Feb 4, 2010·The International Journal of Eating Disorders·Debra L SaferJames Lock
Jun 24, 2015·Current Opinion in Lipidology·Tarza J SiahmansurHandrean Soran
Nov 14, 2008·International Journal of Cardiology·Gillian L Sowden, Jeff C Huffman
Jul 19, 2008·Journal of Psychopharmacology·C MoretM Briley
Jul 12, 2017·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·F CarboneJ Tack
Sep 20, 2018·The Annals of Pharmacotherapy·Meredith L HowardMarian L Gaviola
Jan 11, 2019·JCI Insight·Johannes M HenningsStefan Kloiber
Jan 7, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·G ZhaoA H Mokdad
Apr 23, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Hans-Jürgen Möller
Jun 23, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Jana RadojkovicRade Babic
Mar 21, 2017·BioMed Research International·Yunbao PanYongchang Wei
Jun 25, 2017·Heart Failure Reviews·Diana Stewart, Mary Lynn McPherson
Apr 16, 2021·Journal of Pain & Palliative Care Pharmacotherapy·Kathleen E McGowanChristopher K Finch
Aug 15, 2021·Nutrition Reviews·Jenny G TurcottOscar Arrieta

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here